


The Fund aims to provide capital growth with some income.
| Name | % Net Assets | 
|---|---|
| GlaxoSmithKline PLC | 1.3% | 
| Royal Dutch Shell PLC | 1.2% | 
| BT Group PLC | 1.2% | 
| BG Group PLC | 1.1% | 
| BP PLC | 1.1% | 
| Rolls-Royce Holdings PLC | 0.8% | 
| Rio Tinto PLC | 0.8% | 
| British American Tobacco PLC | 0.8% | 
| Apple Inc. | 0.8% | 
| Legal & General Group PLC | 0.8% | 
| Key | % Net Assets | 
|---|---|
| 1.3% | |
| 1.2% | |
| 1.2% | |
| 1.1% | |
| 95.2% | 
| Date | 09-Apr-2021 | 
|---|---|
| Bid | 208.50p | 
| Offer | 208.50p | 
| Currency | GBP | 
| Change | 1.00p | 
| % | 0.48% | 
| YTD change | 208.50p | 
| YTD % | n/a | 
| Fund Inception | 26/08/1997 | 
|---|---|
| Fund Manager | Sarah Arkle / Alex Lyle | 
| TER | 1.68 (30-Mar-2012) | 
| Minimum Investment | |
|---|---|
| Initial | £2000 | 
| Additional | n/a | 
| Savings | n/a | 
| Charges | |
|---|---|
| Initial | 3.75% | 
| Annual Mang't | 0.25% | 
| Exit | n/a | 
| Name | % | 
|---|---|
| Standard deviation | 0.02 | 
| Sharpe ratio | 0.06 | 
You are here: research